The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
Open accessAbstract
The global incidence of numerous immune-mediated, metabolic, neurodegenerative, and psychiatric diseases is steadily increasing [...]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Increasing Prevalence of Antinuclear Antibodies in the United States
Dinse, G. E., Parks, C. G., Weinberg, C. R., Co, C. A., Wilkerson, J., Zeldin, D. C., Chan, E. K. L., & Miller, F. W. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41214 · Cited by 192
RetractedDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Alterations of the human gut microbiome in liver cirrhosis
Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., et al. (2014) · Nature · doi:10.1038/nature13568 · Cited by 2,177
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. (2014) · Nature · doi:10.1038/nature13793 · Cited by 2,067 · cited 1×
“Paradoxically, non-caloric artificial sweeteners were introduced primarily to prevent metabolic syndrome, but unfortunately, they induce dysbiosis and promote glucose intolerance in a microbiota-dependent manner, leading to the negative metabolic effects that they were intended to prevent [22].”
BackgroundProbiotics and prebiotics in intestinal health and disease: from biology to the clinic
Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0173-3 · Cited by 2,059
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Dysbiosis and the immune system
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A., & Elinav, E. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.7 · Cited by 1,769
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · cited 2×
“The 3-(4-hydroxyphenyl)lactate, a product of aromatic amino acid metabolism, has been associated with liver fibrosis [42]; serum levels of phenylacetic acid correlate with the severity of hepatic steatosis [43]; and succinate produced by NAFLD-associated microbes such as Bacteroidaceae and Prevotella [44] was found to…”
BackgroundPng, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 2×
“At the species level, a decrease in SCFA-producing bacteria such as Faecalibacterium prausnitzii and Clostridium clusters IV, XIVa and XVIII [39] and an increase in sulphate-reducing bacteria (SRB) such as Desulfovibrio [40,41], an increase in mucolytic bacteria such as Ruminococcus gnavus and Ruminococcus torques [26…”
BackgroundWang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317
Yeoh, Y. K., Zuo, T., Lui, G. C.-Y., Zhang, F., Liu, Q., Li, A. Y., Chung, A. C., Cheung, C. P., Tso, E. Y., Fung, K. S., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323020 · Cited by 1,317
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Kostic, A. D., Gevers, D., Siljander, H., Vatanen, T., Hyötyläinen, T., Hämäläinen, A.-M., Peet, A., Tillmann, V., Pöhö, P., Mattila, I., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.001 · Cited by 1,186
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123
Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
Probiotics for prevention of necrotizing enterocolitis in preterm infants
AlFaleh, K., & Anabrees, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005496.pub4 · Cited by 956
Huang, I., Lim, M. A., & Pranata, R. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.018 · Cited by 933
Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N., Singla, V., Khare, S., & Srivastava, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.044 · Cited by 776
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., Heymes, C., Luque, J. L., Anthony, E., Barton, R. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0061-3 · Cited by 720 · cited 1×
“The 3-(4-hydroxyphenyl)lactate, a product of aromatic amino acid metabolism, has been associated with liver fibrosis [42]; serum levels of phenylacetic acid correlate with the severity of hepatic steatosis [43]; and succinate produced by NAFLD-associated microbes such as Bacteroidaceae and Prevotella [44] was found to…”
BackgroundBurden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study
Collaborators, G. 2. U. N. D., Feigin, V. L., Vos, T., Alahdab, F., Amit, A. M. L., Bärnighausen, T. W., Beghi, E., Beheshti, M., Chavan, P. P., Criqui, M. H., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4152 · Cited by 622
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
Takahashi, K., Nishida, A., Fujimoto, T., Fujii, M., Shioya, M., Imaeda, H., Inatomi, O., Bamba, S., Andoh, A., & Sugimoto, M. (2016) · Digestion · doi:10.1159/000441768 · Cited by 599
Chassaing, B., Van de Wiele, T., De Bodt, J., Marzorati, M., & Gewirtz, A. T. (2017) · Gut · doi:10.1136/gutjnl-2016-313099 · Cited by 590 · cited 1×
“For example, dietary emulsifiers directly alter the composition of the human gut microbiota and trigger intestinal inflammation [20].”
BackgroundIntestinal fungi contribute to development of alcoholic liver disease
Yang, A.-M., Inamine, T., Hochrath, K., Chen, P., Wang, L., Llorente, C., Bluemel, S., Hartmann, P., Xu, J., Koyama, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90562 · Cited by 464
High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity
Schulz, M. D., Atay, Ç., Heringer, J., Romrig, F. K., Schwitalla, S., Aydin, B., Ziegler, P. K., Varga, J., Reindl, W., Pommerenke, C., et al. (2014) · Nature · doi:10.1038/nature13398 · Cited by 453
Harrison, S. A., Rinella, M. E., Abdelmalek, M. F., Trotter, J. F., Paredes, A. H., Arnold, H. L., Kugelmas, M., Bashir, M. R., Jaros, M. J., Ling, L., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30474-4 · Cited by 425
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery
Aron-Wisnewsky, J., Prifti, E., Belda, E., Ichou, F., Kayser, B. D., Dao, M. C., Verger, E. O., Hedjazi, L., Bouillot, J.-L., Chevallier, J.-M., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316103 · Cited by 418
Cipriani, S., Mencarelli, A., Palladino, G., & Fiorucci, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001602 · Cited by 416
Lee, G., You, H. J., Bajaj, J. S., Joo, S. K., Yu, J., Park, S., Kang, H., Park, J. H., Kim, J. H., Lee, D. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18754-5 · Cited by 395 · cited 1×
“found a strong association of Veillonellaceae with liver fibrosis in non-obese NAFLD patients and propose Veillonellaceae as a diagnostic marker [29].”
BackgroundSulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases
Loubinoux, J., Bronowicki, J., Pereira, I. A. C., Mougenel, J.-L., & Faou, A. L. (2002) · FEMS Microbiology Ecology · doi:10.1016/s0168-6496(02)00201-5 · Cited by 388
Chu, H., Duan, Y., Yang, L., & Schnabl, B. (2019) · Gut · doi:10.1136/gutjnl-2018-316307 · Cited by 354 · cited 2×
“The 3-(4-hydroxyphenyl)lactate, a product of aromatic amino acid metabolism, has been associated with liver fibrosis [42]; serum levels of phenylacetic acid correlate with the severity of hepatic steatosis [43]; and succinate produced by NAFLD-associated microbes such as Bacteroidaceae and Prevotella [44] was found to…”
BackgroundPhilips, C. A., Pande, A., Shasthry, S. M., Jamwal, K. D., Khillan, V., Chandel, S. S., Kumar, G., Sharma, M. K., Maiwall, R., Jindal, A., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.10.029 · Cited by 349
Baunwall, S. M. D., Lee, M. M., Eriksen, M. K., Mullish, B. H., Marchesi, J. R., Dahlerup, J. F., & Hvas, C. L. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100642 · Cited by 300
Bajaj, J. S., Salzman, N. H., Acharya, C., Sterling, R. K., White, M. B., Gavis, E. A., Fagan, A., Hayward, M., Holtz, M. L., Matherly, S., et al. (2019) · Hepatology · doi:10.1002/hep.30690 · Cited by 295
Verbeke, L., Farre, R., Trebicka, J., Komuta, M., Roskams, T., Klein, S., Elst, I. V., Windmolders, P., Vanuytsel, T., Nevens, F., et al. (2014) · Hepatology · doi:10.1002/hep.26939 · Cited by 258
Rodriguez-Palacios, A., Harding, A., Menghini, P., Himmelman, C., Retuerto, M., Nickerson, K. P., Lam, M., Croniger, C. M., McLean, M. H., Durum, S. K., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy060 · Cited by 225 · cited 1×
“Artificial sweeteners, such as Splenda, promote proteobacterial dysbiosis and exacerbate ileitis in SAMP1/YitFc (SAMP) mice [21].”
BackgroundWeitkunat, K., Stuhlmann, C., Postel, A., Rumberger, S., Fankhänel, M., Woting, A., Petzke, K. J., Gohlke, S., Schulz, T. J., Blaut, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06447-x · Cited by 207
Caussy, C., Hsu, C., Lo, M., Liu, A., Bettencourt, R., Ajmera, V. H., Bassirian, S., Hooker, J., Sy, E., Richards, L., et al. (2018) · Hepatology · doi:10.1002/hep.29892 · Cited by 205
Collins, S. M., Kassam, Z., & Bercik, P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.004 · Cited by 205
IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM
Catanzaro, J. R., Strauss, J. D., Bielecka, A., Porto, A. F., Lobo, F. M., Urban, A., Schofield, W. B., & Palm, N. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-49923-2 · Cited by 198
The Gut Microbiota and Liver Disease
Llorente, C., & Schnabl, B. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.04.003 · Cited by 190
The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials
Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2019) · Cell Transplantation · doi:10.1177/0963689719873890 · Cited by 188
Fecal microbiota transplantation therapy for Parkinson's disease: A preliminary study
Xue, L.-J., Yang, X.-Z., Tong, Q., Shen, P., Ma, S.-J., Wu, S.-N., Zheng, J.-L., & Wang, H.-G. (2020) · Medicine · doi:10.1097/md.0000000000022035 · Cited by 186
Hrncir, T., Hrncirova, L., Kverka, M., Hromadka, R., Machova, V., Trckova, E., Kostovcikova, K., Kralickova, P., Krejsek, J., & Tlaskalova-Hogenova, H. (2021) · Microorganisms · doi:10.3390/microorganisms9050957 · Cited by 174
Self-citationFickert, P., Fuchsbichler, A., Moustafa, T., Wagner, M., Zollner, G., Halilbasic, E., Stöger, U., Arrese, M., Pizarro, M., Solís, N., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090114 · Cited by 169
Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice
Vinolo, M. A. R., Rodrigues, H. G., Festuccia, W. T., Crisma, A. R., Alves, V. S., Martins, A. R., Amaral, C. L., Fiamoncini, J., Hirabara, S. M., Sato, F. T., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00053.2012 · Cited by 167
Mardini, H. E., & Grigorian, A. Y. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000084 · Cited by 155
Zinkevich, V., & Beech, I. B. (2000) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2000.tb00764.x · Cited by 142
Tian, H., Ge, X., Nie, Y., Yang, L., Ding, C., McFarland, L. V., Zhang, X., Chen, Q., Gong, J., & Li, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171308 · Cited by 134
Szajewska, H., Kołodziej, M., Gieruszczak‐Białek, D., Skórka, A., Ruszczyński, M., & Shamir, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15267 · Cited by 125
TMA, A Forgotten Uremic Toxin, but Not TMAO, Is Involved in Cardiovascular Pathology
Jaworska, K., Hering, D., Mosieniak, G., Bielak-Żmijewska, A., Pilz, M., Konwerski, M., Gąsecka, A., Kapłon‐Cieślicka, A., Filipiak, K. J., Sikora, E., et al. (2019) · Toxins · doi:10.3390/toxins11090490 · Cited by 106
Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential
Hussain, I., Cher, G. L. Y., Abid, M. A., & Abid, M. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765965 · Cited by 83
Human gut microbes are susceptible to antimicrobial food additives in vitro
Hrncirova, L., Hudcovic, T., Sukova, E., Machova, V., Trckova, E., Krejsek, J., & Hrncir, T. (2019) · Folia Microbiologica · doi:10.1007/s12223-018-00674-z · Cited by 77
Self-citationBrandt, L. J., Borody, T. J., & Campbell, J. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182257d4f · Cited by 73
Hrncirova, L., Machova, V., Trckova, E., Krejsek, J., & Hrncir, T. (2019) · Microorganisms · doi:10.3390/microorganisms7100383 · Cited by 72
Self-citationKohnert, E., Kreutz, C., Binder, N., Hannibal, L., Gorkiewicz, G., Müller, A., Storz, M. A., Huber, R., & Lederer, A. (2021) · Microorganisms · doi:10.3390/microorganisms9040727 · Cited by 55
Fecal transplantation for ulcerative colitis: current evidence and future applications
Lopetuso, L. R., Ianiro, G., Allegretti, J. R., Bibbò, S., Gasbarrini, A., Scaldaferri, F., & Cammarota, G. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1733964 · Cited by 43
Cui, J., Lin, Z., Tian, H., Yang, B. K., Zhao, D., Ye, C., Li, N., Qin, H., & Chen, Q. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.710452 · Cited by 41
Shahinozzaman, M., Raychaudhuri, S., Fan, S., & Obanda, D. N. (2021) · Microorganisms · doi:10.3390/microorganisms9020238 · Cited by 38
The role of gut microbiota in intestinal and liver diseases
Hrncir, T., Hrncirova, L., Kverka, M., & Tlaskalová‐Hogenová, H. (2018) · Laboratory Animals · doi:10.1177/0023677218818605 · Cited by 32
Self-citationvan der Merwe, M., Moore, D., Hill, J. L., Keating, F. H., Buddington, R. K., Bloomer, R. J., Wang, A., & Bowman, D. D. (2021) · Microorganisms · doi:10.3390/microorganisms9040843 · Cited by 19
Afridi, O. K., Ali, J., & Chang, J. H. (2021) · Microorganisms · doi:10.3390/microorganisms9030616 · Cited by 13
Hvas, C. L., Baunwall, S. M. D., & Erikstrup, C. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100436 · Cited by 6
Cited by
Effects of Probiotics on Gut Microbiota: An Overview
Chandrasekaran, P., Weiskirchen, S., & Weiskirchen, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116022 · Cited by 382
Gut microbiota in multiple sclerosis and animal models
Schumacher, S. M., Doyle, W. J., Hill, K., & Ochoa‐Repáraz, J. (2025) · The FEBS Journal · doi:10.1111/febs.17161 · Cited by 21
Shedding light on the impacts of Spirulina platensis on gut microbiota and related health benefits
Alves, J. L. D. B., Costa, P. C. T. D., Sales, L. C. S. D., Silva Luis, C. C., Bezerra, T. P. T., Souza, M. L. A., Costa, B. A., & de Souza, E. L. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2323112 · Cited by 21
Gazalian, D., Aliahmadi, A., & Rafati, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143634 · Cited by 18
Weizmannia coagulans: an Ideal Probiotic for Gut Health
Zhang, S., Li, P., Lee, S., Wang, Y., Tan, C., & Shang, N. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250002 · Cited by 18
Metadata
- Authors
- Hrncir, T.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2022-03-07
- Volume
- 10
- Issue
- 3
- Pages
- 578
- ISSN
- 2076-2607 (ISSN-L)
- OpenAlex
- W4220763552
- Cited by
- 433
- References
- 75
- FWCI
- 22.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.